Seems to be a full day in the news:
First, the National Institute of Health is reporting that is has begun a clinical trial on a new medication for Alcohol Use Disorder.
“A clinical trial investigating a potential treatment for alcohol use disorder (AUD) was announced by the National Institute of Alcohol Abuse and Alcoholism (NIAAA). The study will assess the safety and efficacy of gabapentin enacarbil (HORIZANT) in extended-release tablets for treating moderate to severe AUD. NIAAA is part of the National Institutes of Health.”
Read the full article here: http://www.nih.gov/news/health/jun2015/niaaa-25.htm
Second, most know at this point that the U.S. Supreme Court released its opinion earlier in the day in the case of King v. Burwell, in which the plaintiffs were challenging whether the federal government could provide insurance subsidies to the poor in those states which refused to open their own health insurance exchanges. In a 6-3 opinion (which is much stronger than a philosophically divided 5-4 opinion and is again written by Chief Justice Roberts himself), the Court upheld the subsidies (viewed as a major win for health care advocates and the Obama Administration).